Research Ethics and Policy Series (REPS) | Genevieve Kanter, PhD

The Revolving Door in Health Policy and the FDA

Genevieve Kanter, PhD
Assistant Professor of Medicine and Medical Ethics, Perelman School of Medicine

Register in advance via Zoom:
https://zoom.us/j/94075904209 

As the Biden administration begins to select its nominees for political appointments, there has been renewed concern about the corrupting effects of the "revolving door." In the context of regulation, the revolving door is defined as the movement of employees between regulatory agencies and the industries they regulate and is thought to render regulatory decisions more vulnerable to industry interests. I review federal revolving door regulations and recent empirical studies on the effects of the revolving door and present a preliminary analysis of the problem of the revolving door in health policy, the FDA, and research standards for drug approval.

Please contact Mary Pham (mary.pham@pennmedicine.upenn.edu) if you would like to be added to the Medical Ethics events listserv.